Biomedical Market Newsletter articles from July 2002

Biomedical Market Newsletter archives from July 2002

Medical association urges FDA to require bar codes on medical product packages: medical errors in hospitals continue to cost lives & money. (Breaking News).(American Society of Health-System Pharmacists)
July 31, 2002... On July 26, 2002, the American Society of Health-System Pharmacists (ASHP) urged the Food & Drug Administration (FDA) to move quickly in requiring bar codes on all medication packages. The association claims the action would significantly...

New solution invented for organ procurement. (Breaking News).(UW Solution)
July 31, 2002... JULY 17, 2002 -- In the late 1980s, Univ of Wisconsin-Madison researchers developed a synthetic solution that could safely store organs outside the body for longer than ever before. Their advance, known as the UW Solution, became the gold...

FDA extends comment period for 1st Amendment. (Breaking News).(Brief Article)
July 31, 2002... July 3, 2002 -- FDA is extending the time period for public comment on how FDA regulation of commercial speech can most effectively safeguard the public health, while also complying with 1st Amendment Constitutional protections (see BMN, p. 39,...

Antigenics Inc. (NASDAQ:AGEN) said in July 2002, that the FDA has granted the company's personalized cancer vaccine Oncophage[R] (HSPPC-96), orphan drug status for the treatment of metastatic melanoma. (Breaking News).
July 31, 2002... Antigenics Inc. (NASDAQ:AGEN) said in July 2002, that the FDAhas granted the company's personalized cancer vaccine Oncophage[R] (HSPPC-96), orphan drug status for the treatment of metastatic melanoma. The action provides Antigenics with...

How much is spent on healthcare? (Breaking News).(Brief Article)
July 31, 2002... During 2001, overall healthcare expenditures in the US passed $1.35 trillion

CDRH funding to rise by $18 mln. (Breaking News).(Center for Devices and Radiological Health)(Brief Article)
July 31, 2002... JULY 25, 2002 -- The Senate Agriculture/FDA Appropriations Subcommittee has approved $18 mln in additional funds to speed-up medical device reviews at the FDA Center for Devices & Radiological Health.

Karl Storz wins reversal at US Court of Appeals on reuse/remanufacture case; case may set precedent for other device mfgrs. (Breaking News).
July 31, 2002... JUNE 25, 2002 -- LOS ANGELES CA -- Karl Storz Endoscopy, an international medical device manufacturer, announced that it has won a significant battle in its ongoing efforts to stop third-party repair companies from compromising its reputation...

FDA steps up surveillance of medical devices to prevent unforeseen problems, better protect patients. (Breaking News).
July 31, 2002... JUNE 05, 2002 -- To reduce the number of unforeseen adverse events from medical device failure, the FDA today announced that it will require manufacturers of certain critical medical devices to conduct post-market surveillance of those...

FDA destroys unsafe medical devices after they are seized; company owners flee the country. (Breaking News).(A and A Medical Inc/Rocket USA/LifeQuest Medical Inc. devices destroyed)(Brief Article)
July 31, 2002... JULY 12, 2002 -- The FDA announced today that products manufactured by A & A Medical Inc/Rocket USA/LifeQuest Medical Inc of Alpharetta GA, were destroyed on July 11, 2002 as a result of regulatory actions by the FDA. The firm's owners...

Aksys Ltd. (NASDAQ:AKSY).(appoints Larry Damron senior vice president chief financial officer)(Brief Article)
July 31, 2002... LINCOLNSHIRE IL -- Larry Damron is its new Sr VP/CFO, and was CFO for Everest Healthcare Services Corp, said Bill Dow, President/CEO.

Alloy Polymers Inc. (privately held).(Brief Article)
July 31, 2002... RICHMOND VA -- Anthony Bernardo is its new Licensed Products Director.

Alpha Therapeutic Corp., Div. of Mitsubishi Pharma Corp. (TKO Exchange).(appoints David Hirsch senior vice president)(Brief Article)
July 31, 2002... LOS ANGELES CA -- David Hirsch is its new Sr VP of Worldwide Sales & Marketing, from VP of Sales & Marketing at Nexell Therapeutics, said Edward A. Colton, President & CEO.

American Medical Group Association.(Brief Article)
July 31, 2002... ALEXANDRIA VA -- Debra Cohn is its new VP of Public Policy & Government Affairs, said President & CEO Donald W. Fisher, Ph.D. She was Legislative Counsel to the American College of Physicians-American Society of Internal Medicine.

Augustine Medical Inc.(Brief Article)
July 31, 2002... EDEN PRAIRIE MN -- Company founder Scott Augustine has stepped down from his role as Chairman & CEO, and is now Chief Technology Officer and Medical Director.

Bacterial Bar Codes Inc. (privately held).(Brief Article)
July 31, 2002... HOUSTON TX -- Dr. Mimi Healy is its new Chief Scientific Officer, said N.J. Pierce, CEO. She was Project Manager at Visible Genetics Inc.

Beckman Coulter Inc. (NYSE:BEC).(Brief Article)
July 31, 2002... FULLERTON CA -- Scott Garrett is the new President of its Clinical Diagnostics Division, succeeding Albert Ziegler, who retired.

BioTransplant (NASDAQ:BTRN).(Brief Article)
July 31, 2002... CHARLESTOWN MA -- Donald B. Hawthorne is its new President & Chief Executive Officer, succeeding Elliot Lebowitz, who is now Chairman of the Board. Hawthorne was President of Hawk & Associates Inc.

Caprion Pharmaceuticals Inc. (privately held).(Brief Article)
July 31, 2002... MONTREAL QUE CANADA -- Dr. Daniel Chelsky is its new Chief Scientific Officer. He was President/ GM of BioSignal Packard Inc (a division of Perkin Elmer Inc), said Lloyd M. Segal, President/CEO.

Celera Genomics, Div. of Applera Corp. (NYSE:CRA).(Brief Article)
July 31, 2002... ROCKVILLE MD -- Robert F.G. Booth, Ph.D., is its new Sr VP of R&D, announced Kathy Ordonez, President. He was previously Sr VP of Inflammatory & Viral Diseases Business Unit, Hoffmann-La Roche.

Centerpulse Ltd. (NYSE:CEP).(Brief Article)
July 31, 2002... ZURICH SWITZERLAND -- Centerpulse, formerly Sulzer Medica, has named Suha Demokan as Head of Investor Relations. Demokan replaces Anja Stubenrauch, who held the position on an interim basis. Also, Board Chairman Max Link is the new CEO,...

Chase Medical LP.(Brief Article)
July 31, 2002... RICHARDSON TX -- Glenn R. Webb is its new VP of Global Sales and Mary Kay Baggs, is now VP of Global Marketing.

Cohesive Technologies Inc (privately held).(Brief Article)
July 31, 2002... FRANKLIN MA -- John Coursen was promoted to VP of Marketing & Sales and Managing Director of European Operations, said Peter H. Glick, CEO. Joseph M. Di Bussolo, Ph.D., has also been named Director of Field Applications, said Joseph Takarewski,...

Consumer Healthcare Products Association.(Brief Article)
July 31, 2002... WASHINGTON DC -- Linda A. Suydam, formerly FDA Sr Associate Commissioner for Communications & Constituent Relations (informally, the No. 2 official at FDA w/the absence of a permanent FDA Commissioner), left June 1, 2002, to become CHPA's...

C.R. Bard (NYSE:BCR).(Brief Article)
July 31, 2002... MURRAY HILL NJ -- Holly Glass was promoted to VP of Government & Public Relations.

CTI Molecular Imaging (NASDAQ:CTMI).(Brief Article)
July 31, 2002... KNOXVILLE TN -- Thomas Hook is the new President of CTI Services, and Sr VP of CTI Molecular Imaging. Hook is the former GM of Global Functional & Molecular Imaging at GE Medical Systems.

Deltagen (NASDAQ:DGEN).(Brief Article)
July 31, 2002... REDWOOD CITY CA -- Geoffrey Yarranton is its new Exec VP of R&D, announced its Chairman/CEO, William Matthews.

Exelixis Inc (NASDAQ:EXEL).(Brief Article)
July 31, 2002... SOUTH SAN FRANCISCO CA -- Steven A. Lacy, Ph.D. is its new Sr Dir of Preclinical Development, said Jeffrey Latts, M.D., Sr VP/Chief Medical Officer.

FeRx Inc (privately held).(Brief Article)
July 31, 2002... SAN DIEGO CA -- Gilad S. Gordon, M.D., MBA, is its new VP of Medical Affairs, from Director of Clinical Research at Ribozyme Pharmaceuticals (Boulder CO), said Jacqueline Johnson, Ph.D., President/CEO.

Flemington Pharmaceuticals Corp (BB:FLEM).(Brief Article)
July 31, 2002... FLEMINGTON NJ -- Mohammed Abd El-Shafy, PhD, is its new VP of Formulation Development. He was the Senior Scientist at Nastech Pharmaceutical Inc, announced Dr. Harry Dugger, President/CEO.

Genmab A/S (Copenhagen:GEN.CO).(Brief Article)
July 31, 2002... COPENHAGEN DENMARK -- Torben Lund-Hansen is its new VP of Manufacturing. He was Dir of Development, Process & Manufacturing at Maxygen, announced Jesper Zeuthen, Chairman.

GPC Biotech AG (FSE:GPC).(Brief Article)
July 31, 2002... MARTINSRIED/MUNICH (GERMANY) & WALTHAM/ BOSTON MA--Sebastian Meier-Ewert, Ph.D., was promoted to Chief Scientific Officer/COO of its Waltham/Boston site. Marcel Rozencweig, M.D., continues as Sr VP of Drug Development. GPC Biotech also expanded...

Hemedex Inc (privately-held).(Brief Article)
July 31, 2002... CAMBRIDGE MA -- William Reed is its new Vice Chairman, announced H. Fredrick Bowman, Ph.D., Chairman/President/CEO. Michael T. McCartin is its new VP of Marketing & Sales.

Impax Laboratories Inc (NASDAQ:IPXL).(Brief Article)
July 31, 2002... HAYWARD CA -- Marc Cantillon, M.D., is its new VP of Clinical Development, announced Charles Hsaio, Chairman/Co-CEO, Barry R. Edwards, Co-CEO, and Larry Hsu, Ph.D, President/COO.

Lexicon Genetics Inc (NASDAQ:LEXG).(Brief Article)
July 31, 2002... THE WOODLANDS TX -- Lorraine Marchand is its new VP of Corporate Communications, from Bristol-Myers Squibb Co (NYSE: BMY), where she was Executive Director in the Pharmaceutical Research Institute, said Arthur T. Sands, M.D., Ph.D., President &...

MDS Pharma Services (TSE:MDS; NYSE:MDZ).(Brief Article)
July 31, 2002... PHILADELPHIA PA -- Dr Michael J Butler is the new Sr VP Business Development for Early Clinical Research & Bioanalysis. Amy Gray is its new Sr Director Service Leadership, said Gilbert Godin, President.

Medarex Inc (NASDAQ:MEDX).(Brief Article)
July 31, 2002... PRINCETON NJ -- Israel Lowy, M.D., Ph.D. is its new Director, Infectious Diseases, said Donald L. Drakeman, President & CEO.

MedSynergies Inc (privately held).(Brief Article)
July 31, 2002... IRVING TX -- Steve Williams, is its new VP of Sales & Marketing, announced J.R. Thomas, Pres/CEO.

Meridian Medical Technologies (NASDAQ:MTEC).(Brief Article)
July 31, 2002... COLUMBIA MD -- Carl Rebert is its new President of Cardiopulmonary Systems; he was President of Vesta Medical, announced James H. Miller, Chairman/President/ CEO.

Moore Medical Corp (AMEX:MMD).(Brief Article)
July 31, 2002... NEW BRITAIN CT -- John M. Zinzarella was promoted to CFO, a post previously held by James R. Simpson, who left to pursue other interests.

PacifiCare Health Systems (NASDAQ:PHSY).(Brief Article)
July 31, 2002... SANTA ANA CA -- Sam Ho, M.D., is its new Sr VP Chief Medical Officer and Pete McKinley, is its new Sr VP Network Management

Paradigm Genetics Inc (NASDAQ:PDGM).(Brief Article)
July 31, 2002... RESEARCH TRIANGLE PARK NC -- Heinrich Gugger, Ph.D., is its new President/CEO. He was President of Syngenta Crop Protection Inc. John Hamer, Ph.D., former Interim President/CEO of Paradigm, will continue to serve as its Chief Scientific...

Prana Biotechnology Ltd (NASDAQ:PRNAF; ASX: PBT).(Brief Article)
July 31, 2002... MELBOURNE AUSTRALIA -- Dr. Ross Murdoch is its new COO, from CEO/Chief Scientific Officer of Kinacia, formerly Thrombogenix (Australia), announced Executive Chairman Geoffrey Kempler.

Protein Design Labs Inc (NASDAQ:PDLI).(Brief Article)
July 31, 2002... FREMONT CA -- Laurence Jay Korn, Ph.D., Co-Founder, has relinquished his responsibilities as CEO, but continues to serve as Chairman. Douglas O. Ebersole, its Sr VP Legal & Licensing, will serve as CEO on an interim basis. Daniel J. Levitt,...

PsychoGenics Inc (privately held).(Brief Article)
July 31, 2002... HAWTHORNE NY -- Mark Hofer, Esq. is its new General Counsel, from Brown Rudnick Berlack & Israels, announced Emer Leahy, Ph.D., President/CEO. Mark A. Klitenick, Ph.D. is its new VP of Behavioral Operations, from the Janssen Research...

Symmetry Medical Inc (privately held).(Brief Article)
July 31, 2002... WARSAW IN -- Steffan Burns is its new President/ CEO, from Paladin Associates, announced James A. Conroy, Chairman. Andy Miclot was promoted to Sr VP Sales, Marketing & Business Development.

Timm Medical Technologies Inc, Div of Endocare Inc (NASDAQ:ENDO).(Brief Article)
July 31, 2002... EDEN PRAIRIE MN -- Gerald R. Mattys is the new President/CEO.

Toshiba America Medical Systems Inc Div.(Brief Article)
July 31, 2002... IRVINE CA -- Lawrence Dentice is the new VP of Sales.

USANA Health Sciences Inc. (NASDAQ:USNA).(Brief Article)
July 31, 2002... SALT LAKE CITY UT -- David Wentz was promoted to President, which was previously held by its founder, Dr. Myron Wentz.

US Food & Drug Administration.(Brief Article)
July 31, 2002... WASHINGTON DC -- The FDA promoted staff members to two new office director positions: Robert Meyer will head the Office of Drug Evaluation II, and Jonca Bull is the new Director, Office of Drug Evaluation.

US National Institutes of Health.(Brief Article)
July 31, 2002... BETHESDA MD -- Roderic Pettigrew was named the first permanent director of NIH's National Institute of Biomedical Imaging & Bioengineering (NIBIB). He was a professor of radiology, medicine (cardiology) and bioengineering, and Director of the...

US Surgeon General.(Brief Article)
July 31, 2002... WASHINGTON DC -- The Senate approved President Bush's nomination of Richard Carmona to serve as US Surgeon General by a voice vote on July 23, 2002. Carmona, a professor at the University of Arizona, succeeds David Satcher, whose four-year term...

Vela Pharmaceuticals (privately held).(Brief Article)
July 31, 2002... LAWRENCEVILLE NJ -- Jeff Calcagno, MD, formerly of McKinsey, is its new CFO & VP of Finance.

Watson Pharmaceuticals Inc (NYSE:WPI).(Brief Article)
July 31, 2002... CORONA CA -- Robert C. Funsten, its Sr VP & General Counsel, left to pursue other opportunities. Michel J. Feldman, an attorney and Watson board member, will serve as interim general counsel, said Allen Chao, Ph.D., Chairman/CEO. Andrew Boyer...

Julie Gerberding MD MPH, named CDC Director & ATSDR Administrator. (People News).
July 31, 2002... WASHINGTON DC -- JULY 03, 2002 -- DHHS Secretary Tommy G. Thompson today named Julie L. Gerberding, M.D., M.P.H., to be Director of the US Centers for Disease Control & Prevention (CDC) and Administrator for the Agency for Toxic Substances &...

FDA special agent receives fraud prevention award; Tap Pharmaceuticals agreed to pay $875 mln to resolve the criminal & civil liabilities. (Breaking News).(Brief Article)
July 31, 2002... JULY 17, 2002 -- The FDA announced that Special Agent Tom Harkness in the FDA's Office of Criminal Investigations today received the US Attorney General's Award for Fraud Prevention. The award was presented in recognition of Special Agent...

FDA warns about PVC devices containing DEHP plasticizer. (Breaking News).(polyvinyl chloride, di(2-ethylhexyl)phthalate)
July 31, 2002... JULY 12, 2002 -- FDA's CDRH completed its safety assessment of Di(2-ethylhexyl)phthalate (DEHP) released from polyvinyl chloride (PVC) medical devices in Sept. 2001, and announced the following steps to take to reduce the risk of exposure in...

California's business climate ranks 6th worst in the US: SBSC's 2002 annual state rankings. (Association Viewpoints).(Small Business Survival Committee)(Brief Article)
July 31, 2002... WASHINGTON DC -- JULY 29, 2002 -- The Small Business Survival Committee (SBSC), a national trade associaton, released its annual rankings of state business climates today. According the new "Small Business Survival Index 2002," California ranks...

SBSC urges senate to oppose drug reimportation. (Association Viewpoints).(Small Business Survival Committee)(Brief Article)
July 31, 2002... WASHINGTON DC -- JULY 17, 2002 -- The Small Business Survival Committee (SBSC) today announced its "strong opposition to proposals being put forth to authorize the reimportation of prescription drugs into this country." Darrell McKigney,...

FDA suspends operations of medical gas facility. (FDA Investigations).(Brief Article)
July 31, 2002... WASINGINGTON DC -- JUNE 18, 2002 -- The FDA has shut down certain operations of Air Liquide America Corp (ALAC), a medical gas facility in Coatesville PA. FDA officials claim the company had failed to assure that its industrial-grade trailers...

Humanitarian device determination comments requested by FDA. (Breaking News).(Brief Article)
July 31, 2002... JULY 31, 2002 -- The FDA announced it is inviting public comment on information collection requirements regarding humanitarian use device (HUD) determinations. The FDA invites comments by Sept. 30, 2002, on how the FDA gathers/uses these...

Steris to work with US army to evaluate how to combat biochemical contamination. (Breaking News).(Brief Article)
July 31, 2002... JULY 29, 2002 -- MENTOR OH -- Steris Corp (NYSE:STE) today announced that its subsidiary, Strategic Technology Enterprises, Inc., and the US Army Edgewood Chemical Biological Center (ECBC), have entered into an agreement to conduct a...

FDA review & approval times for new drugs have shortened. (Drug Discovery).(Brief Article)
July 31, 2002... JULY 29, 2002 -- BOSTON MA -- The amount of time required by the US FDA to review and approve new drugs and biopharmaceuticals has shortened substantially under the Prescription Drug User Fee Act (PDFUA), a new analysis released today by the...

Pharmaceutical firms made 32 new treatments available in 2001; companies invested estimated $30.3 bln in R&D. (Market Research Studies).(Brief Article)
July 31, 2002... WASHINGTON DC -- In 2001, pharmaceutical and biotech companies added 32 new treatments to the nation's medicine chest--24 drugs and 8 biologics, the Pharmaceutical Research & Manufacturers of America (PhRMA) recently announced. "As we...

Too many line extensions claims controversial new study. (Market Research Studies).(Brief Article)
July 31, 2002... MAY 29 2002 -- The drug industry has developed very few new drugs over the last decade, instead centering its resources on making and selling line extensions that offer "no significant clinical improvement over older medications," claims a new...

Drug discovery technology firms to watch. (Market Research Studies).
July 31, 2002... Astex Technology Cambridge England http://www.astex-technology.com Astex Technology is a private structure-based drug discovery company pioneering the use of high through-put X-ray crystallography for the rapid design and development...

New data projects Alzheimer's disease in US could affect up to 16 mln by 2050; research estimates current Alzheimer population at 4.5 mln. (Market Research Studies).(million)(Brief Article)(Statistical Data Included)
July 31, 2002... STOCKHOLM SWEDEN -- JULY 22, 2002 -- New research released today at the 8th International Conference on Alzheimer's Disease & Related Disorders, sponsored by the Alzheimer's Association, indicates that the prevalence of the disease in the US...

Coronary artery bypass graft (CABG) surgery may be associated with increased risk of stroke & long-term cognitive changes: patients with risk factors for cerebrovascular disease are at greatest risk. (Market Research Studies).(Brief Article)
July 31, 2002... STOCKHOLM SWEDEN -- JULY 22, 2002 -- New findings reported at the 8th International Conference on Alzheimer's Disease & Related Disorders suggest that coronary artery bypass grafting (CABG), an effective technique for treating heart disease,...

Alzheimer's disease drug research status. (Market Research Studies).(Brief Article)
July 31, 2002... Source: Alzheimer Research Forum NAME: ABT 418 FDA PHASE: Discontinued NAME: Acetyl-l-carnitine HCI OTHER NAMES: ALCAR FDA PHASE: Discontinued ROLE IN ALZHEIMER'S DISEASE: Lessen cognitive deterioration NAME: AF 102B...

Alzheimer's disease drugs in clinical trials. (Market Research Studies).(Brief Article)
July 31, 2002... Source: Alzheimer Research Forum NAME: Metrifonate FDA PHASE: Discontinued ROLE IN ALZHEIMER'S DISEASE: Improve cognition and behavioral symptoms in mild/moderate AD. NAME: Milameline OTHER NAMES: CI 979 ROLE IN ALZHEIMER'S...

Alzheimer's disease drug therapies in the pipeline. (Market Research Studies).(Brief Article)
July 31, 2002... The following is a list of pharmaceutical companies that have Alzheimer therapies in the pipeline and/or have a focus on neurodegenerative diseases. Abbott Laboratories Corp 100 Abbott Park Rd Abbott Park IL 60064-3500 847-937-4956...

Opportunities in nanostructured biomedical materials & pharmaceuticals; biotech market for nanoparticles to reach $144.8 mln in 2005, claims new study. (Market Research Studies).
July 31, 2002... Business Communications Company, Inc. Norwalk CT In recent years, the biotech community has discovered that the distinctive physical characteristics and novel properties of nanoparticles--their extraordinarily high surface area-to-volume...

$400 bln worldwide drug industry continues to evolve; only 3 of 10 brand name drugs generate enough revenues to cover R&D costs, says study. (Market Research Studies).
July 31, 2002... Business Communications Company, Inc. Norwalk CT Everyday the scientific community is presenting new discoveries relating to the human genome and its potential in providing new drugs and related therapies. At the same time, many consumers...

New developments in drug discovery. (Market Research Studies).(Brief Article)
July 31, 2002... Business Communications Company, Inc. Norwalk CT. The very foundations of drug discovery research are being rapidly transformed by robotics, high throughput systems, automated assays, and advanced software systems. Costs are dropping, the...

Antibiotics market to top $34.5 bln by 2006; in 2001-2006, approx. 40 new products or new product formulations may be introduced. (Market Research Studies).
July 31, 2002... Business Communications Company, Inc. Norwalk CT The continuing emergence of antibiotic resistance threatens to reverse the progress made during the latter half of the 20th century, to effectively treat bacterial and other infectious...

Inhibitor & blocker drug market to top $176 bln by 2006; enzyme inhibitors will grow at an AAGR of 8% through 2006, to $95.6 bln. (Market Research Studies).
July 31, 2002... Business Communications Company, Inc. Norwalk CT A significant percentage of all drugs work by acting as antagonists. That is to say, they gain their effect by stopping a biological process from happening. Since it is usually easier to stop...

Swiss medical manufacturing industry study: news update of the market research study published in the Nov. 2001 issue of Biomedical Market Newsletter. (Market Research Studies).
July 31, 2002... * 3M (Minneapolis MN) -- The drug delivery systems unit of 3M has formed an alliance with Novartis Pharma AG (Switzerland) to explore future manufacturing opportunities for new Novartis inhalation products. * Amgen (Thousand Oaks CA) -- the...

NIHCM Foundation responds to PhRMA's criticisms of the report, "Changing Patterns of Pharmaceutical Innovation". (Guest Editorial).
July 31, 2002... June 13, 2002 NIHCM Foundation stands by its report 100%. The report uses objective data and a robust methodology to address issues of broad concern to policy makers and the public. "Changing Patterns of Pharmaceutical Innovation"...

Controversy over importation of pharmaceuticals into the US. (Guest Editorial).
July 31, 2002... Testimony presented July 9, 2002, to: Special Committee on Aging US Senate Washington DC. William K. Hubbard Sr Associate Commissioner, Policy, Planning, Legislation Washington DC I appreciate the opportunity to discuss our mutual...

Almost 200 medicines are in development for children; survey says 194 being developed by 93 firms. (Market Research Studies).
July 31, 2002... WASHINGTON DC -- May 29 2002 -- A new survey by the Pharmaceutical Research & Manufacturers of America (PhRMA) finds 194 new medicines are in development for children by 93 pharmaceutical and biotech companies. "These new medicines in...

Pfizer to acquire Pharmacia for $60 bln. (Breaking News).
July 31, 2002... JULY 15, 2002 -- NEW YORK NY -- Pfizer Inc (NYSE: PFE) and Pharmacia Corp (NYSE: PHA) jointly announced today that they have signed a definitive agreement providing for Pfizer to acquire Pharmacia in a stock-for-stock transaction valued at $60...

China issues sterilization standards. (Breaking News).(Brief Article)
July 31, 2002... JUNE 21 2002 -- BEIJING CHINA -- The China Ministry of Health annnounced today new Administrative Measures on Sterilizing of Medical Instruments. Notification No. TBT-CHN-03-02 covers sanitary products, disposable medical products,...

Marketing, advertising & administration: excerpts from the new July 2002 study, "Profiting From Pain; Where Prescription Drug Dollars Go". (Market Research Studies).
July 31, 2002... Families USA Washington DC Company spending on marketing, advertising, and administration both highlights the industry's attention to marketing and deflates its argument that R&D would necessarily be the area to suffer if drug prices were...

Pharmaceutical industry profile 2002: excerpts of important new 115-page study. (Market Research Studies).
July 31, 2002... Pharmaceutical Research & Manufacturers of America Washington DC Welcome Message From Alan F. Holmer: PhRMA is pleased to present the 2002 edition of the Pharmaceutical Industry Profile, a report on one of the world's most innovative,...

Bush Administration backs pharmaceutical industry over the needs of millions of senior citizens. (Guest Editorial).
July 31, 2002... JULY 11, 2002 -- WASHINGTON DC -- Ron Pollack, Executive Director of Families USA, the national organization for health care consumers, released the following statement today concerning the DHHS report on prescription drugs and medical...